Back to News
Market Impact: 0.3

MannKind Corporation Reports Third Quarter 2026 Financial Results

Source: Nasdaq

Corporate EarningsHealthcare & BiotechCompany Fundamentals

MannKind reported Q3 2026 total revenue of $101.9 million, up 24% year over year. Commercial product revenue was $45.0 million, up 102% year over year; the provided article text ends before giving further details.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.35

Ticker Sentiment

MNKD0.65

More News

From AllMind Research

Browse all research